Latest news from Abbott Molecular on Newswise en-us Copyright 2024 Newswise 115 31 / /images/newswise-logo-rss.gif /articles/fish-technology-preferred-for-choosing-her-2-positive-breast-cancer-treatments/?sc=rsin /articles/fish-technology-preferred-for-choosing-her-2-positive-breast-cancer-treatments/?sc=rsin Fri, 20 Nov 2009 09:00:00 EST The debate on how to select patients who will respond best to costly drug treatments for aggressive breast cancer now favors fluorescence in situ hybridization (FISH) to measure the HER-2 receptor found in human breast tumors, according to a leading pathologist presenting at the Association for Molecular Pathology annual meeting. Abbott Molecular /articles/new-abbott-technology-offers-rapid-alternative-to-culture-for-microbial-detection/?sc=rsin /articles/new-abbott-technology-offers-rapid-alternative-to-culture-for-microbial-detection/?sc=rsin Fri, 20 Nov 2009 08:00:00 EST Research presented today at the Association for Molecular Pathology (AMP) annual meeting indicates that a new molecular diagnostic technology from Abbott identified more microbes and delivered more rapid results than traditional culture testing methods. Abbott Molecular